AbbVie Begins $70M Expansion At AbbVie Bioresearch Center In Worcester; Expansion To Create New Jobs And Strengthen U.S. Manufacturing Footprint Supporting Over 6,000 Positions

Author: Benzinga Newsdesk | September 30, 2025 03:06pm

• Expansion increases biologics manufacturing for immunology and oncology medicines
• Milestone marks progress on AbbVie's long-term commitment to U.S. manufacturing
• Furthers longstanding commitment to AbbVie's Massachusetts sites and workforce

NORTH CHICAGO, Ill., Sept. 30, 2025 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.

With a presence in all 50 states and Puerto Rico, AbbVie employs 28,000 people in the U.S., including more than 2,000 in Massachusetts. This expansion will create new jobs at the ABC site and add additional capabilities to AbbVie's U.S. manufacturing footprint, which supports more than 6,000 American jobs across 11 manufacturing sites.

Posted In: ABBV